BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37212422)

  • 1. A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts.
    Nikiforova MN; Wald AI; Spagnolo DM; Melan MA; Grupillo M; Lai YT; Brand RE; O'Broin-Lennon AM; McGrath K; Park WG; Pfau PR; Polanco PM; Kubiliun N; DeWitt J; Easler JJ; Dam A; Mok SR; Wallace MB; Kumbhari V; Boone BA; Marsh W; Thakkar S; Fairley KJ; Afghani E; Bhat Y; Ramrakhiani S; Nasr J; Skef W; Thiruvengadam NR; Khalid A; Fasanella K; Chennat J; Das R; Singh H; Sarkaria S; Slivka A; Gabbert C; Sawas T; Tielleman T; Vanderveldt HD; Tavakkoli A; Smith LM; Smith K; Bell PD; Hruban RH; Paniccia A; Zureikat A; Lee KK; Ongchin M; Zeh H; Minter R; He J; Nikiforov YE; Singhi AD
    Ann Surg; 2023 Oct; 278(4):e789-e797. PubMed ID: 37212422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts.
    Paniccia A; Polanco PM; Boone BA; Wald AI; McGrath K; Brand RE; Khalid A; Kubiliun N; O'Broin-Lennon AM; Park WG; Klapman J; Tharian B; Inamdar S; Fasanella K; Nasr J; Chennat J; Das R; DeWitt J; Easler JJ; Bick B; Singh H; Fairley KJ; Sarkaria S; Sawas T; Skef W; Slivka A; Tavakkoli A; Thakkar S; Kim V; Vanderveldt HD; Richardson A; Wallace MB; Brahmbhatt B; Engels M; Gabbert C; Dugum M; El-Dika S; Bhat Y; Ramrakhiani S; Bakis G; Rolshud D; Millspaugh G; Tielleman T; Schmidt C; Mansour J; Marsh W; Ongchin M; Centeno B; Monaco SE; Ohori NP; Lajara S; Thompson ED; Hruban RH; Bell PD; Smith K; Permuth JB; Vandenbussche C; Ernst W; Grupillo M; Kaya C; Hogg M; He J; Wolfgang CL; Lee KK; Zeh H; Zureikat A; Nikiforova MN; Singhi AD
    Gastroenterology; 2023 Jan; 164(1):117-133.e7. PubMed ID: 36209796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue.
    Laquière AE; Lagarde A; Napoléon B; Bourdariat R; Atkinson A; Donatelli G; Pol B; Lecomte L; Curel L; Urena-Campos R; Helbert T; Valantin V; Mithieux F; Buono JP; Grandval P; Olschwang S
    World J Gastroenterol; 2019 Sep; 25(36):5530-5542. PubMed ID: 31576098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.
    Rosenbaum MW; Jones M; Dudley JC; Le LP; Iafrate AJ; Pitman MB
    Cancer Cytopathol; 2017 Jan; 125(1):41-47. PubMed ID: 27647802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas.
    Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL
    Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sendai and Fukuoka Consensus Guidelines Identify Advanced Neoplasia in Patients With Suspected Mucinous Cystic Neoplasms of the Pancreas.
    Kaimakliotis P; Riff B; Pourmand K; Chandrasekhara V; Furth EE; Siegelman ES; Drebin J; Vollmer CM; Kochman ML; Ginsberg GG; Ahmad NA
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1808-15. PubMed ID: 25818077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study.
    Volckmar AL; Endris V; Gaida MM; Leichsenring J; Stögbauer F; Allgäuer M; von Winterfeld M; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Schirmacher P; Rudi J; Schmitz D; Stenzinger A
    Genes Chromosomes Cancer; 2019 Jan; 58(1):3-11. PubMed ID: 30230086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation.
    Ren R; Krishna SG; Chen W; Frankel WL; Shen R; Zhao W; Avenarius MR; Garee J; Caruthers S; Jones D
    Mod Pathol; 2021 Feb; 34(2):438-444. PubMed ID: 32792597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study.
    Fulmer CG; Park K; Dilcher T; Ho M; Mirabelli S; Alperstein S; Hissong EM; Pittman M; Siddiqui M; Heymann JJ; Yantiss RK; Borczuk AC; Fernandes H; Sigel C; Song W; Mosquera JM; Rao R
    Cancer Cytopathol; 2020 Nov; 128(11):840-851. PubMed ID: 32598087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.
    Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J
    Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.
    Hata T; Dal Molin M; Hong SM; Tamura K; Suenaga M; Yu J; Sedogawa H; Weiss MJ; Wolfgang CL; Lennon AM; Hruban RH; Goggins MG
    Clin Cancer Res; 2017 Jul; 23(14):3935-3944. PubMed ID: 28148542
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
    Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
    Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of commercial DNA analysis in detecting malignancy within pancreatic cysts.
    Lee LS; Wu BU; Banks PA; Kadiyala V; Mehta S; Saltzman JR; Thompson CC; Bellizzi AM
    JOP; 2013 Mar; 15(2):182-8. PubMed ID: 24618422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.